Publication / Source: Neuro Central
Authors: Sharon Salt, Editor
The Alzheimer’s & Parkinson’s Disease Congress (AD/PD™; 26–31 March 2019, Lisbon, Portugal) welcomed over 3740 delegates this year to hear all the latest research and developments in the field of dementia. It was extremely heartwarming and inspiring to see such a large research community invested in improving the treatment and care of people living with these diseases.
Over the week, we heard various talks across many key areas in the research field, ranging from prevention and resilience in dementia, to translational treatment strategies, animal models and much more. In this report, I’ll share with you some of my key moments and takeaway messages from the conference.
Landmarks in Alzheimer’s disease
While walking around and familiarizing myself with the conference venue on the first morning, I was pleased to stumble across a walkway that had a timeline of landmarks in Alzheimer’s disease. It was really fascinating to see key milestones in the research field, and I knew I had to share this with everyone once I was back! There are a few videos and images of this available on the #ADPD2019 hashtag on Twitter but you can also find it below:
Credit: AD/PD™ Congress organizers.
TREM2 and microglia
One hot topic in dementia research right now revolves around microglia and neuroinflammation, so it was no surprise that there was a lot of focus being put into this area during the conference.